Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 0.75 (1.91%)
Spread: 2.00 (5.128%)
Open: 38.50
High: 40.00
Low: 38.50
Prev. Close: 39.25
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UltraDEX update

30 Apr 2018 07:00

RNS Number : 4552M
Venture Life Group PLC
30 April 2018
 

Venture Life Group plc

("Venture Life" or "the Company")

 

UltraDEX update

 

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market announces an update on the UltraDEX brand. The Company has extended its agreement with key French distributor La Brosse et Dupont SAS ("La Brosse") to include the UltraDEX Sensitive toothpaste. The launch will take place in H2 2018 and follows the successful launch of the original UltraDEX range in Q1 2018 in France.

 

Founded in 1932, La Brosse is a former subsidiary of LVMH Moet Hennessy Louis Vuitton S.E. It serves customers through large and medium commercial outlets throughout France, including Leclerc and Carrefour, and has market leading products within the oral healthcare space. Le Brosse launched the original UltraDEX range into the French market during March 2018 and is building up a presence in the grocery multiples.

 

UltraDEX was also partnered in Italy and the Nordics in 2017, and after delivery of product in Q4 2017, these partners have also launched UltraDEX into their respective markets during H1 2018. Both partners are building a presence for the mouthwash, toothpaste and spray products in pharmacies and dentists, and early indications are positive for the sell through.

 

Separately, the Company announces the launch of the new UltraDEX 'One GoÔ' range in all 797 of the Superdrug stores in the UK from June 2018. UltraDEX 'One Go' is another new innovative line extension from the Company, providing single use sachets of the UltraDEX mouthwash.

 

Jerry Randall, CEO of Venture Life commented: "The extension of this agreement with La Brosse is a real testament to the continued international success of UltraDEX, particularly at such an early stage in their launch of the UltraDEX range in France. I am delighted with the continued commercial development of the UltraDEX brand both in the UK and internationally, and we look forward updating the market further throughout the rest of the year.

 

"It's also great news that our new product, UltraDEX 'One Go', has been so quickly adopted by one of the leading pharmacy chains, Superdrug, demonstrating our ability to rapidly develop and launch innovative new products into the consumer self-care channel, and we are hopeful to extend its presence further. Innovation is key to the growth of consumer brands, and Venture Life has the experience and capabilities to develop and commercialise such new products."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

 

 

 

Enquiries

 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

Adrian Crockett, Chief Financial Officer

 

Northland Capital Partners Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3861 6625

Matthew Johnson/Edward Hutton (Corporate Finance)

Bob Pountney (Corporate Broking)

Turner Pope Investments (TPI) Ltd (Joint Broker)

+44 (0) 20 3621 4120

Andy Thacker

Walbrook PR

venturelife@walbrookpr.com or +44 (0) 20 7933 8780

Anna Dunphy/Paul McManus

+44 (0) 7876 741 001 / +44 (0) 7980 541 893

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLLFLESDIDFIT
Date   Source Headline
10th May 202211:31 amRNSExercise of Share Options & Voting Rights
19th Apr 20227:00 amRNSReporting Update
23rd Mar 20223:00 pmRNSAnnouncement re: Full year results
22nd Feb 20227:00 amRNSGrant of Options and PDMR Dealing
21st Feb 20227:00 amRNSResults - clinical trial led by Cardiff University
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:37 pmRNSPrice Monitoring Extension
31st Jan 20222:06 pmRNSSecond Price Monitoring Extn
31st Jan 20222:01 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Statement
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSBusiness Update
29th Dec 202112:34 pmRNSDirector/PDMR Shareholding
20th Dec 20214:13 pmRNSDirectorate Change
14th Dec 202111:05 amRNSSecond Price Monitoring Extn
14th Dec 202111:01 amRNSPrice Monitoring Extension
3rd Dec 20214:22 pmRNSDirector/PDMR Shareholding
1st Dec 20219:06 amRNSSecond Price Monitoring Extn
1st Dec 20219:00 amRNSPrice Monitoring Extension
1st Dec 20217:00 amRNSTrading Update & Board Changes
1st Nov 20212:00 pmRNSPrice Monitoring Extension
1st Nov 20218:44 amRNSHolding(s) in Company
1st Nov 20218:43 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSHolding(s) in Company
11th Oct 20212:41 pmRNSHolding(s) in Company
23rd Sep 20219:05 amRNSSecond Price Monitoring Extn
23rd Sep 20219:00 amRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSHalf-year Report
7th Sep 20211:54 pmRNSHolding(s) in Company
13th Aug 20219:05 amRNSSecond Price Monitoring Extn
13th Aug 20219:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSTrading Update and Progress on recent Acquisitions
6th Aug 20217:00 amRNSAcquisition of Oncology Support Product Assets
21st Jun 20217:00 amRNSRevolving Credit Facility
7th Jun 20217:00 amRNSAcquisition of BBI Healthcare Limited
20th May 20212:29 pmRNSResult of AGM
14th Apr 20214:19 pmRNSHolding(s) in Company
25th Mar 20212:19 pmRNSConfirmation of AGM Date
25th Mar 20217:00 amRNSFinal Results
25th Feb 20217:00 amRNSInvestor Presentation
1st Feb 20217:00 amRNSTrading Update & Notice of Results
14th Dec 20202:07 pmRNSIssue of Equity
11th Dec 20207:27 amRNSHolding(s) in Company
10th Dec 20204:45 pmRNSHolding(s) in Company
10th Dec 20204:41 pmRNSHolding(s) in Company
10th Dec 20202:42 pmRNSHolding(s) in Company
10th Dec 20201:45 pmRNSHolding(s) in Company
9th Dec 20202:28 pmRNSDirector/PDMR Shareholding
8th Dec 202012:00 pmRNSResult of General Meeting and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.